GOED on new cancer study: ‘Results do not support a change in omega-3 intake’

GOED on new cancer study: ‘Results do not support a change in omega-3 intake’

A new study that links omega-3 intakes and an increased risk of endometrial cancer changes nothing for current recommendations for omega-3s, says the Global Organization for EPA and DHA Omega-3s (GOED).

Epidemiological data published in the American Journal of Clinical Nutrition by Theodore Brasky and his team from The Ohio State University suggested that there was an association between high omega-3 intakes and an increased risk of endometrial cancer in overweight and obese women.

On the other hand, increased intakes of omega-3s for normal-weight women were associated with statistically significant reductions in cancer risk, said the researchers.

The only other study examining specific omega-3 intakes and endometrial cancer was performed by Hannah Arem et al. from Yale School of Public Health, which found that high intakes of omega-3s may reduce the risk of this particular cancer (European Journal of Nutrition, 2013, Vol. 52, pp. 1251-60. doi: 10.1007/s00394-012-0436-z).

However, other studies examining fish intake and endometrial cancer have found a positive association.

Commenting on the study’s findings, Harry Rice, PhD, V.P., Regulatory & Scientific Affairs for GOED, told us: “While results from this study may provide a reason to conduct further research at some point in time, they do not support a change (increase or decrease) in omega-3 intake.”

That prostate cancer study

The study’s findings may attract attention since the authors, Brasky et al., were also involved in last year’s controversial prostate cancer study. That study has been widely debated in omega-3 circles, with many taking exception to the conclusions.

Indeed, the prostate cancer study, which was published in the Journal of the National Cancer Institute (doi: 10.1093/jnci/djt174), was also epidemiological and again showed correlation and not causation. It also only measured blood levels of omega-3s and did not consider any differences between fish and supplements. Despite this, co-author Dr Alan Kristal from Fred Hutchinson Cancer Research Center, USA, stated: “We've shown once again that use of nutritional supplements may be harmful.”

Endometrial study

For the new study, Dr Brasky and his co-workers examined intakes of long-chain omega-3s, including EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in 22,494 women aged between 50 and 76 living in Washington State. Intakes from the diet and supplements were assessed using a semi-quantitative food-frequency questionnaire (FFQ).

Over nine years of data collection, there were 263 cases of endometrial cancers documented.

Results showed that women with the highest average dietary intakes of EPA + DHA (over 256 mg per day) had a 79% increased risk of endometrial cancer, compared to women with the lowest average intakes (less than 60 mg per day). Further number crunching showed that the increases in risk were restricted to overweight and obese women, whereas statistically significant reductions in risk were observed for normal-weight women.

“When supplemental exposures were considered in addition to diet, the findings were similar,” added Dr Brasky and his co-authors.

“In this large prospective study, we found that intake of long-chain omega-3 PUFAs and their food sources are positively associated with endometrial cancer risk among overweight and obese women,” they wrote. “In normal-weight women, long-chain omega-3 fatty acids may provide some benefit.

“Because this is an observational study, replication in randomized trials is necessary to confirm these findings. One such study, the ongoing VITamin D and Omega-3 TriAL (VITAL), may be helpful in verifying the results we report here.”

Source: American Journal of Clinical Nutrition
Published online ahead of print, doi:10.3945/ajcn.113.070524
“Associations of long-chain omega-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort”
Authors: Theodore M Brasky, Marian L Neuhouser, David E Cohn, and Emily White

Related News

Lonza and DSM end decade-long patent dispute over DHA

Lonza and DSM settle omega-3 patent dispute

The rule to prohibit statements on the labels of food products and dietary supplements that claim the products are “high in” DHA or EPA, and synonyms such as “rich in” and “excellent source of"

FDA prohibition of omega-3 nutrient content claims ‘in no way reflects the well-substantiated benefits associated with EPA & DHA’, says GOED

Is the omega-3 sector in decline?

Is the omega-3 sector in decline?

Research directly challenges a previous study which found that omega-3s increase the risk of prostate cancer

Omega-3 may help fight prostate cancer

Not just industry slamming omega-3-prostate cancer links

Not just industry slamming omega-3-prostate cancer links

A high intake of omega-3 from food or supplements puts people in the highest risk category for aggressive prostate cancers, according to the new research.

High levels of long chain omega-3 may increase prostate cancer risk: Study

Omega-3 may increase prostate cancer risk, but benefits outweigh: Study

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.